 | Up a level |
Ahmed, Mohamed E; Todenhöfer, Tilman; Karnes, R Jeffrey; Seiler, Roland (2022). Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers. European urology focus, 8(3), pp. 663-666. Elsevier 10.1016/j.euf.2022.06.009
Cacciamani, Giovanni E; Maas, Marissa; Nassiri, Nima; Ortega, David; Gill, Karanvir; Dell'Oglio, Paolo; Thalmann, George; Heidenreich, Axel; Eastham, James A; Evans, Christopher P; Karnes, R Jeffrey; De Castro Abreu, Andre L; Briganti, Alberto; Artibani, Walter; Gill, Inderbir; Montorsi, Francesco (2021). Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis. European urology oncology, 4(2), pp. 134-149. Elsevier 10.1016/j.euo.2021.02.001
Tosco, Lorenzo; Laenen, Annouschka; Briganti, Alberto; Gontero, Paolo; Karnes, R Jeffrey; Bastian, Patrick J; Chlosta, Piotr; Claessens, Frank; Chun, Felix K; Everaerts, Wouter; Gratzke, Christian; Albersen, Maarten; Graefen, Markus; Kneitz, Burkhard; Marchioro, Giansilvio; Salas, Rafael Sanchez; Tombal, Bertrand; Van den Broeck, Thomas; Van Der Poel, Henk; Walz, Jochen; ... (2018). The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. European urology focus, 4(3), pp. 369-375. Elsevier 10.1016/j.euf.2016.12.008
Zhao, Shuang G; Chang, S Laura; Erho, Nicholas; Yu, Menggang; Lehrer, Jonathan; Alshalalfa, Mohammed; Speers, Corey; Cooperberg, Matthew R; Kim, Won; Ryan, Charles J; Den, Robert B; Freedland, Stephen J; Posadas, Edwin; Sandler, Howard; Klein, Eric A; Black, Peter; Seiler, Roland; Tomlins, Scott A; Chinnaiyan, Arul M; Jenkins, Robert B; ... (2017). Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA oncology, 3(12), pp. 1663-1672. American Medical Association 10.1001/jamaoncol.2017.0751
Alshalalfa, Mohammed; Verhaegh, Gerald W; Gibb, Ewan A; Santiago-Jiménez, Maria; Erho, Nicholas; Jordan, Jennifer; Yousefi, Kasra; Lam, Lucia L C; Kolisnik, Tyler; Chelissery, Jijumon; Seiler, Roland; Ross, Ashley E; Karnes, R Jeffrey; Schaeffer, Edward M; Lotan, Tamara T; Den, Robert B; Freedland, Stephen J; Davicioni, Elai; Klein, Eric A and Schalken, Jack A (2017). Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients. OncoTarget, 8(31), pp. 50804-50813. Impact Journals LLC 10.18632/oncotarget.15133
Moschini, Marco; Spahn, Martin; Mattei, Agostino; Cheville, John; Karnes, R Jeffrey (2016). Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics. BMC medicine, 14(1), p. 67. BioMed Central 10.1186/s12916-016-0613-7
Spahn, Martin; Boxler, Silvan; Joniau, Steven; Moschini, Marco; Tombal, Bertrand; Karnes, R Jeffrey (2015). What is the Need for Prostatic Biomarkers in Prostate Cancer Management? Current urology reports, 16(10), p. 70. Current Science 10.1007/s11934-015-0545-3
Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven; Vander Eeckt, Kathy; Serretta, Vincenzo; Larré, Stéphane; Di Stasi, Savino; Van Rhijn, Bas; Witjes, Alfred J; Grotenhuis, Anne J; Kiemeney, Lambertus A; Colombo, Renzo; Briganti, Alberto; Babjuk, Marek; Malmström, Per-Uno; Oderda, Marco; Irani, Jacques; Malats, Nuria; Baniel, Jack; ... (2015). Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. European urology, 67(1), pp. 74-82. Elsevier 10.1016/j.eururo.2014.06.040
Joniau, Steven; Briganti, Alberto; Gontero, Paolo; Gandaglia, Giorgio; Tosco, Lorenzo; Fieuws, Steffen; Tombal, Bertrand; Marchioro, Giansilvio; Walz, Jochen; Kneitz, Burkhard; Bader, Pia; Frohneberg, Detlef; Tizzani, Alessandro; Graefen, Markus; van Cangh, Paul; Karnes, R Jeffrey; Montorsi, Francesco; Van Poppel, Hein; Spahn, Martin (2015). Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study. European urology, 67(1), pp. 157-164. Elsevier 10.1016/j.eururo.2014.01.020
Joniau, Steven; Spahn, Martin; Briganti, Alberto; Gandaglia, Giorgio; Tombal, Bertrand; Tosco, Lorenzo; Marchioro, Giansilvio; Hsu, Chao-Yu; Walz, Jochen; Kneitz, Burkhard; Bader, Pia; Frohneberg, Detlef; Tizzani, Alessandro; Graefen, Markus; van Cangh, Paul; Karnes, R Jeffrey; Montorsi, Francesco; van Poppel, Hein; Gontero, Paolo (2015). Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate Cancer. European urology, 67(2), pp. 319-325. Elsevier 10.1016/j.eururo.2014.03.013
Schubert, Maria; Joniau, Steven; Gontero, Paolo; Kneitz, Susanne; Scholz, Claus-Jürgen; Kneitz, Burkhard; Briganti, Alberto; Karnes, R Jeffrey; Tombal, Bertrand; Walz, Jochen; Hsu, Chao-Yu; Marchioro, Giansilvio; Bader, Pia; Bangma, Chris; Frohneberg, Detlef; Graefen, Markus; Schröder, Fritz; van Cangh, Paul; van Poppel, Hein and Spahn, Martin (2012). The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis. Advances in urology, 2012, p. 612707. Cairo (Egypt): Hindawi Publishing Corporation 10.1155/2012/612707
Briganti, Alberto; Joniau, Steven; Gontero, Paolo; Abdollah, Firas; Passoni, Niccolò M; Tombal, Bertrand; Marchioro, Giansilvio; Kneitz, Burkhard; Walz, Jochen; Frohneberg, Detlef; Bangma, Chris H; Graefen, Markus; Tizzani, Alessandro; Frea, Bruno; Karnes, R Jeffrey; Montorsi, Francesco; Van Poppel, Hein; Spahn, Martin (2012). Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. European urology, 61(3), pp. 584-92. Amsterdam: Elsevier 10.1016/j.eururo.2011.11.043
